{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:09:17Z","timestamp":1746245357604,"version":"3.40.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s10461-014-0776-1","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T19:29:44Z","timestamp":1398799784000},"page":"2240-2248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Correlates of Unstructured Antiretroviral Treatment Interruption in a Cohort of HIV-Positive Individuals in British Columbia"],"prefix":"10.1007","volume":"18","author":[{"given":"Hasina","family":"Samji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Salters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio S. G.","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"issue":"6","key":"776_CR1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","volume":"52","author":"EM Gardner","year":"2011","unstructured":"Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793\u2013800.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"776_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QAD.0b013e328340feb0","volume":"25","author":"JW Bae","year":"2011","unstructured":"Bae JW, Guyer W, Grimm K, Altice FL. Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS. 2011;25(3):279\u201390.","journal-title":"AIDS"},{"issue":"9740","key":"776_CR3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","volume":"376","author":"JS Montaner","year":"2010","unstructured":"Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376(9740):532\u20139.","journal-title":"Lancet"},{"issue":"1","key":"776_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/588673","volume":"198","author":"VD Lima","year":"2008","unstructured":"Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008;198(1):59\u201367.","journal-title":"J Infect Dis"},{"issue":"6","key":"776_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"key":"776_CR6","doi-asserted-by":"crossref","unstructured":"Walmsley S, Loutfy M. Can structured treatment interruptions (STIs) be used as a strategy to decrease total drug requirements and toxicity in HIV infection? J Int Assoc Physicians AIDS Care (Chic). 2002 Summer;1(3):95\u2013103.","DOI":"10.1177\/154510970200100304"},{"issue":"9534","key":"776_CR7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(06)69153-8","volume":"368","author":"J Ananworanich","year":"2006","unstructured":"Ananworanich J, Gayet-Ageron A, Le Braz M, et al. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet. 2006;368(9534):459\u201365.","journal-title":"Lancet"},{"issue":"22","key":"776_CR8","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","volume":"355","author":"WM El-Sadr","year":"2006","unstructured":"Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283\u201396.","journal-title":"N Engl J Med"},{"key":"776_CR9","doi-asserted-by":"crossref","unstructured":"SMART Study Group, El-Sadr WM, Grund B, et al. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med. 2008;149(5):289\u2013299.","DOI":"10.7326\/0003-4819-149-5-200809020-00003"},{"issue":"5","key":"776_CR10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","volume":"300","author":"SM Hammer","year":"2008","unstructured":"Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300(5):555\u201370.","journal-title":"JAMA"},{"issue":"2","key":"776_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QAD.0b013e3282f2d760","volume":"22","author":"DART Trial Team","year":"2008","unstructured":"DART Trial Team. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts <200\u00a0cells\/microl. AIDS. 2008;22(2):237\u201347.","journal-title":"AIDS"},{"issue":"4","key":"776_CR12","first-page":"236","volume":"10","author":"E Seminari","year":"2008","unstructured":"Seminari E, De Silvestri A, Boschi A, Tinelli C. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis. AIDS Rev. 2008;10(4):236\u201344.","journal-title":"AIDS Rev."},{"issue":"8","key":"776_CR13","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199905280-00001","volume":"13","author":"PR Harrigan","year":"1999","unstructured":"Harrigan PR, Whaley M, Montaner JS. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS. 1999;13(8):F59\u201362.","journal-title":"AIDS"},{"issue":"6","key":"776_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-133-6-200009190-00011","volume":"133","author":"JM Kilby","year":"2000","unstructured":"Kilby JM, Goepfert PA, Miller AP, et al. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: a case report. Ann Intern Med. 2000;133(6):435\u20138.","journal-title":"Ann Intern Med"},{"key":"776_CR15","doi-asserted-by":"crossref","unstructured":"Deeks SG. International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance. J Acquir Immune Defic Syndr. 2001;26 Suppl 1:S25\u2013S33.","DOI":"10.1097\/00126334-200103011-00004"},{"issue":"1","key":"776_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/sti.79.1.74","volume":"79","author":"E Teicher","year":"2003","unstructured":"Teicher E, Casagrande T, Vittecoq D. Enhanced risk of HIV sexual transmission during structured treatment interruption. Sex Transm Infect. 2003;79(1):74.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"776_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002030-200003100-00008","volume":"14","author":"DR Bangsberg","year":"2000","unstructured":"Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357\u201366.","journal-title":"AIDS"},{"issue":"2","key":"776_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11908-002-0059-2","volume":"4","author":"M Dybul","year":"2002","unstructured":"Dybul M. Structured treatment interruption: approaches and Risks. Curr Infect Dis Rep. 2002;4(2):175\u201380.","journal-title":"Curr Infect Dis Rep"},{"key":"776_CR19","unstructured":"Pai NP, Tulsky JP, Lawrence J, Colford JM Jr, Reingold AL. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults. Cochrane Database Syst Rev. 2005;4(4):CD005482."},{"key":"776_CR20","unstructured":"Calmy A, Nguyen A, Montecucco F, for the STACCATO Study Team. HIV activates markers of cardiovascular risk in a randomized treatment interruption trial: STACCATO. Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections 2008."},{"issue":"5","key":"776_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1468-1293.2009.00779.x","volume":"11","author":"DM Moore","year":"2010","unstructured":"Moore DM, Zhang W, Yip B, et al. Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme. HIV Med. 2010;11(5):299\u2013307.","journal-title":"HIV Med"},{"issue":"5","key":"776_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/09540120412331319778","volume":"17","author":"T Kerr","year":"2005","unstructured":"Kerr T, Marshall A, Walsh J, et al. Determinants of HAART discontinuation among injection drug users. AIDS Care. 2005;17(5):539\u201349.","journal-title":"AIDS Care"},{"issue":"3","key":"776_CR23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1468-1293.2006.00355.x","volume":"7","author":"Y Yuan","year":"2006","unstructured":"Yuan Y, L\u2019italien G, Mukherjee J, Iloeje UH. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med. 2006;7(3):156\u201362.","journal-title":"HIV Med"},{"issue":"16","key":"776_CR24","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/00002030-200111090-00005","volume":"15","author":"L Ahdieh Grant","year":"2001","unstructured":"Ahdieh Grant L, Silverberg MJ, Palacio H, et al. Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels. AIDS. 2001;15(16):2101\u20138.","journal-title":"AIDS"},{"issue":"4","key":"776_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00126334-200312010-00008","volume":"34","author":"ME O\u2019Brien","year":"2003","unstructured":"O\u2019Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr. 2003;34(4):407\u201314.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"776_CR26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/01.qai.0000230321.85911.db","volume":"42","author":"G Touloumi","year":"2006","unstructured":"Touloumi G, Pantazis N, Antoniou A, et al. Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences. J Acquir Immune Defic Syndr. 2006;42(5):554\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"776_CR27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1468-1293.2007.00436.x","volume":"8","author":"C Holkmann Olsen","year":"2007","unstructured":"Holkmann Olsen C, Mocroft A, Kirk O, et al. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med. 2007;8(2):96\u2013104.","journal-title":"HIV Med"},{"issue":"5","key":"776_CR28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00002030-200203290-00010","volume":"16","author":"P Taffe","year":"2002","unstructured":"Taffe P, Rickenbach M, Hirschel B, et al. Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study. AIDS. 2002;16(5):747\u201355.","journal-title":"AIDS"},{"issue":"3","key":"776_CR29","first-page":"320","volume":"38","author":"X Li","year":"2005","unstructured":"Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2005;38(3):320\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"776_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","volume":"308","author":"MA Thompson","year":"2012","unstructured":"Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387\u2013402.","journal-title":"JAMA"},{"issue":"20","key":"776_CR31","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","volume":"286","author":"RS Hogg","year":"2001","unstructured":"Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286(20):2568\u201377.","journal-title":"JAMA"},{"issue":"4","key":"776_CR32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.qai.0000147529.57240.b0","volume":"38","author":"A d\u2019arminio Monforte","year":"2005","unstructured":"d\u2019arminio Monforte A, Cozzi-Lepri A, Phillips A, et al. Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients. J Acquir Immune Defic Syndr. 2005;38(4):407\u201316.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 11","key":"776_CR33","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/jn\/120.suppl_11.1544","volume":"120","author":"KL Radimer","year":"1990","unstructured":"Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544\u20138.","journal-title":"J Nutr"},{"issue":"11","key":"776_CR34","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jn\/125.11.2793","volume":"125","author":"A Kendall","year":"1995","unstructured":"Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer\/Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793\u2013801.","journal-title":"J Nutr"},{"key":"776_CR35","volume-title":"Stata statistical software: release 12","author":"LP StataCorp","year":"2011","unstructured":"StataCorp LP. Stata statistical software: release 12. TX: College Station; 2011."},{"issue":"8","key":"776_CR36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/424008","volume":"39","author":"AR Moss","year":"2004","unstructured":"Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004;39(8):1190\u20138.","journal-title":"Clin Infect Dis"},{"key":"776_CR37","unstructured":"BC Centre for Disease Control. HIV in British Columbia: Annual Surveillance Report 2011. 2012(Retrieved from http:\/\/www.bccdc.ca\/util\/about\/annreport\/default.htm )."},{"key":"776_CR38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2334-11-86","volume":"11","author":"C Tapp","year":"2011","unstructured":"Tapp C, Milloy MJ, Kerr T, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"776_CR39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0277-9536(01)00125-3","volume":"54","author":"B Spire","year":"2002","unstructured":"Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med. 2002;54(10):1481\u201396.","journal-title":"Soc Sci Med"},{"issue":"3","key":"776_CR40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00126334-200207010-00012","volume":"30","author":"S Lieb","year":"2002","unstructured":"Lieb S, Brooks RG, Hopkins RS, et al. Predicting death from HIV\/AIDS: a case\u2013control study from Florida public HIV\/AIDS clinics. J Acquir Immune Defic Syndr. 2002;30(3):351\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"776_CR41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/108729103771928708","volume":"17","author":"MO Johnson","year":"2003","unstructured":"Johnson MO, Catz SL, Remien RH, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS. 2003;17(12):645\u201356.","journal-title":"AIDS Patient Care STDS"},{"issue":"11","key":"776_CR42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1525-1497.2004.30445.x","volume":"19","author":"KM Berg","year":"2004","unstructured":"Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19(11):1111\u20137.","journal-title":"J Gen Intern Med"},{"issue":"6 Suppl","key":"776_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10461-007-9246-3","volume":"11","author":"CA Leaver","year":"2007","unstructured":"Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11(6 Suppl):85\u2013100.","journal-title":"AIDS Behav"},{"issue":"11","key":"776_CR44","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1371\/journal.pmed.0030438","volume":"3","author":"EJ Mills","year":"2006","unstructured":"Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.","journal-title":"PLoS Med"},{"issue":"120","key":"776_CR45","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/QAD.0b013e328362fdde","volume":"108","author":"CC Udeagu","year":"2013","unstructured":"Udeagu CC, Webster TR, Bocour A, Michel P, Shepard CW. Lost\u2014or just not following up? Public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS. 2013;108(120):2271.","journal-title":"AIDS"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0776-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-014-0776-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0776-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T16:23:30Z","timestamp":1746203010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-014-0776-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s10461-014-0776-1","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}